| 1 |
apolipoprotein
(4869 times)
|
Biochemistry
(1192 times)
|
HDL (1005 times)
LDL (796 times)
TG (484 times)
|
1976 Catabolism of canine apolipoprotein A-I: purification, catabolic rate, organs of catabolism, and the liver subcellular catabolic site.
|
| 2 |
apoprotein
(152 times)
|
Biochemistry
(31 times)
|
HDL (55 times)
LDL (48 times)
VLDL (32 times)
|
1979 High-density lipoprotein in chronic renal failure and after renal transplantation.
|
| 3 |
anti-apolipoprotein
(19 times)
|
Biochemistry
(6 times)
|
HDL (5 times)
LDL (4 times)
LPL (3 times)
|
1984 Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
|
| 4 |
LDL-apolipoprotein
(18 times)
|
Vascular Diseases
(3 times)
|
HDL (5 times)
TG (5 times)
HDL-C (3 times)
|
1989 Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
|
| 5 |
acceptor
(2 times)
|
Molecular Biology
(2 times)
|
ABC (1 time)
Adx (1 time)
ADXR (1 time)
|
2017 Retinal pigment epithelium cholesterol efflux mediated by the 18 kDa translocator protein, TSPO, a potential target for treating age-related macular degeneration.
|
| 6 |
acid sequence of preproapolipoprotein
(2 times)
|
Biochemistry
(2 times)
|
---
|
1984 Human apolipoprotein A-II: complete nucleic acid sequence of preproapo A-II.
|
| 7 |
atherosclerosis-prone apolipoprotein
(2 times)
|
Medicine
(2 times)
|
ILC2s (1 time)
PC (1 time)
|
2000 Infectious agents are not necessary for murine atherogenesis.
|
| 8 |
cholesterol-apolipoprotein
(2 times)
|
Vascular Diseases
(1 time)
|
LDL (2 times)
HDL (1 time)
IDL (1 time)
|
1995 Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
|
| 9 |
LDL-apoprotein
(2 times)
|
Metabolism
(2 times)
|
Chol (1 time)
FH (1 time)
IDL (1 time)
|
1991 Contribution of glucose tolerance and plasma insulin levels to the relationships between body fat distribution and plasma lipoprotein levels in women.
|
| 10 |
proteins--apolipoprotein
(2 times)
|
Biology
(1 time)
|
FCR (2 times)
HDL (2 times)
SR (1 time)
|
1985 Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
|
| 11 |
125I-apo-DBP
(1 time)
|
Medicine
(1 time)
|
DBP (1 time)
|
1987 Vitamin D binding protein sequesters monomeric actin in the circulation of the rat.
|
| 12 |
125I-apolipoprotein
(1 time)
|
Vascular Diseases
(1 time)
|
HDL (1 time)
|
1986 Tissue sites of degradation of high density lipoprotein apolipoprotein A-IV in rats.
|
| 13 |
125I-apoprotein
(1 time)
|
Biochemistry
(1 time)
|
CE (1 time)
CETP (1 time)
HDL (1 time)
|
1997 Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue.
|
| 14 |
abundant production of apolipoprotein
(1 time)
|
Biology
(1 time)
|
---
|
1995 Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion.
|
| 15 |
Accordingly, we examined the possibility that uptake of iron-free
(1 time)
|
Allergy and Immunology
(1 time)
|
MDM (1 time)
|
1991 Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation.
|
| 16 |
accurate method for ligand-binding site prediction in unbound state
(1 time)
|
Biochemistry
(1 time)
|
---
|
2008 Highly accurate method for ligand-binding site prediction in unbound state (apo) protein structures.
|
| 17 |
activation caused buildup of heme-free
(1 time)
|
Biochemistry
(1 time)
|
iNOS (1 time)
SNO-GAPDH (1 time)
Trx-1 (1 time)
|
2012 Thioredoxin-1 regulates cellular heme insertion by controlling S-nitrosation of glyceraldehyde-3-phosphate dehydrogenase.
|
| 18 |
activator protein, apolipoprotein
(1 time)
|
Medicine
(1 time)
|
HLP (1 time)
|
1982 Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
|
| 19 |
adoption of clinical serum apolipoprotein
(1 time)
|
Chemistry, Clinical
(1 time)
|
ASCVD (1 time)
CVD (1 time)
RMS (1 time)
|
2020 Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration.
|
| 20 |
adsorption of apolipoprotein
(1 time)
|
Science
(1 time)
|
HDL (1 time)
NP (1 time)
QDs (1 time)
|
2013 Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis.
|
| 21 |
advanced profile of serum
(1 time)
|
Chemistry, Clinical
(1 time)
|
CAD (1 time)
ROC (1 time)
|
2006 The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
|
| 22 |
AF, independently of clinical factors
(1 time)
|
Medicine
(1 time)
|
CRP (1 time)
IMT (1 time)
MetS (1 time)
|
2010 Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease.
|
| 23 |
affinity for lipid membranes with molar fraction partition coefficients K(x)()
(1 time)
|
Chemistry
(1 time)
|
---
|
2002 Membrane affinity of the amphiphilic marinobactin siderophores.
|
| 24 |
allosteric proteins uncomplexed
(1 time)
|
Chemistry
(1 time)
|
---
|
2018 Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
|
| 25 |
allows the protein to cycle between open
(1 time)
|
Chemical Phenomena
(1 time)
|
DCM (1 time)
QSFR (1 time)
|
2008 Hydrogen bond networks determine emergent mechanical and thermodynamic properties across a protein family.
|
| 26 |
alpha-amino-n-butyric acid to leucine ratio, macrocytosis, carbohydrate-deficient transferrin
(1 time)
|
Chemistry, Clinical
(1 time)
|
---
|
1998 Determination of biological markers for alcohol abuse.
|
| 27 |
alpha-helices of exchangeable apolipoproteins
(1 time)
|
Biochemistry
(1 time)
|
CD (1 time)
HDL (1 time)
|
1993 Physical properties of apolipoprotein A-I from the chicken, Gallus domesticus.
|
| 28 |
alpha2 and flanking residues are disordered in the AdGST1-4
(1 time)
|
Biochemistry
(1 time)
|
Ad (1 time)
GSTs (1 time)
|
2001 The crystal structures of glutathione S-transferases isozymes 1-3 and 1-4 from Anopheles dirus species B.
|
| 29 |
also expanded to include iron-bound and iron-free
(1 time)
|
Biochemistry
(1 time)
|
---
|
2012 A structural perspective on lactoferrin function.
|
| 30 |
also promotes hepatic apolipoprotein
(1 time)
|
Biochemistry
(1 time)
|
---
|
2013 The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis.
|
| 31 |
amplitude requires only three
(1 time)
|
Molecular Biology
(1 time)
|
ANS (1 time)
I-FABP (1 time)
MRD (1 time)
|
1999 Water molecules in the binding cavity of intestinal fatty acid binding protein: dynamic characterization by water 17O and 2H magnetic relaxation dispersion.
|
| 32 |
analbuminemic rats: effects of pravastatin on plasma
(1 time)
|
Biochemistry
(1 time)
|
HDL (1 time)
LCAT (1 time)
NAR (1 time)
|
1991 Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity.
|
| 33 |
antibody-carbohydrate co-complexes and three unliganded
(1 time)
|
Chemistry
(1 time)
|
MD (1 time)
|
2018 Applying Pose Clustering and MD Simulations To Eliminate False Positives in Molecular Docking.
|
| 34 |
antiinflammatory properties of apolipoprotein
(1 time)
|
Vascular Diseases
(1 time)
|
ICAM-1 (1 time)
rHDL (1 time)
VCAM-1 (1 time)
|
2010 Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
|
| 35 |
apoA-IMilano/POPC infusion on lipids
(1 time)
|
Biochemistry
(1 time)
|
FC (1 time)
HDL-C (1 time)
PL (1 time)
|
2013 Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.
|
| 36 |
APOAI polymorphisms and HDL-C, apolipoprotein
(1 time)
|
Metabolism
(1 time)
|
HDL-C (1 time)
Lp (1 time)
PRIME (1 time)
|
2009 Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
|
| 37 |
apolipoprotein of human HDL, apolipoprotein
(1 time)
|
Biochemistry
(1 time)
|
HDL (1 time)
|
1992 Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoprotein A-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection.
|
| 38 |
apoplastic space
(1 time)
|
Biochemistry
(1 time)
|
chl (1 time)
cyto (1 time)
htTG (1 time)
|
2008 Molecular farming of human tissue transglutaminase in tobacco plants.
|
| 39 |
aposymbiotic
(1 time)
|
Microbiological Phenomena
(1 time)
|
Sym (1 time)
|
2019 Persistent symbiont colonization leads to a maturation of hemocyte response in the Euprymna scolopes/Vibrio fischeri symbiosis.
|
| 40 |
appearance of large and apolipoprotein
(1 time)
|
Gastroenterology
(1 time)
|
HDL (1 time)
HSPGs (1 time)
SDC1 (1 time)
|
2007 Adenovirus-mediated hepatic syndecan-1 overexpression induces hepatocyte proliferation and hyperlipidaemia in mice.
|
| 41 |
approach significantly improves the docking performance, using unbound
(1 time)
|
Biochemistry
(1 time)
|
RMSDs (1 time)
|
2003 Protein-protein docking with a reduced protein model accounting for side-chain flexibility.
|
| 42 |
areuginosa, the core complex in the Mla pathway, in nucleotide-free
(1 time)
|
Molecular Biology
(1 time)
|
ABC (1 time)
LPS (1 time)
Mla (1 time)
|
2021 Structural Insight into Phospholipid Transport by the MlaFEBD Complex from P. aeruginosa.
|
| 43 |
aspartate receptor have been determined in the absence
(1 time)
|
Biochemistry
(1 time)
|
---
|
1993 The three-dimensional structure of the ligand-binding domain of a wild-type bacterial chemotaxis receptor. Structural comparison to the cross-linked mutant forms and conformational changes upon ligand binding.
|
| 44 |
assess possible involvement of apolipoprotein
(1 time)
|
Vascular Diseases
(1 time)
|
HFH (1 time)
LDL (1 time)
|
1992 Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins.
|
| 45 |
associations of plasma
(1 time)
|
Biochemistry
(1 time)
|
T2DM (1 time)
|
2014 Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
|
| 46 |
atheroprotective properties of apolipoprotein
(1 time)
|
Vascular Diseases
(1 time)
|
---
|
2011 ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium.
|
| 47 |
attempts to crystallize ligand-free
(1 time)
|
Medicine
(1 time)
|
---
|
2015 Solution Structural Studies of GTP:Adenosylcobinamide-Phosphateguanylyl Transferase (CobY) from Methanocaldococcus jannaschii.
|
| 48 |
attendant proton-induced interfering fluorescence of the metal-free
(1 time)
|
Biochemistry
(1 time)
|
PET (1 time)
ZP (1 time)
|
2004 Bright fluorescent chemosensor platforms for imaging endogenous pools of neuronal zinc.
|
| 49 |
CETP-apolipoprotein
(1 time)
|
Medicine
(1 time)
|
CETP (1 time)
HDL-C (1 time)
RCT (1 time)
|
2012 CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic mice.
|
| 50 |
image processing of nucleotide-free
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2013 Flexibility within the heads of muscle myosin-2 molecules.
|
| 51 |
internal pair of helices B/C
(1 time)
|
Biochemistry
(1 time)
|
---
|
1988 Refined structure of chicken skeletal muscle troponin C in the two-calcium state at 2-A resolution.
|
| 52 |
intestinal-apolipoprotein
(1 time)
|
Obesity
(1 time)
|
CVD (1 time)
TG (1 time)
|
2020 ApoB-lipoprotein remnant dyslipidemia and high-fat meal intolerance is associated with markers of cardiometabolic risk in youth with obesity.
|
| 53 |
LDL-associated proteins apolipoprotein
(1 time)
|
Internal Medicine
(1 time)
|
AGE (1 time)
LDL (1 time)
T2DM (1 time)
|
2011 LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome.
|
| 54 |
lipoprotein-apolipoprotein
(1 time)
|
Metabolism
(1 time)
|
ASCVD (1 time)
FH (1 time)
LDL (1 time)
|
2021 Unravelling lipoprotein metabolism with stable isotopes: tracing the flow.
|
| 55 |
terminal pair of helices A/D
(1 time)
|
Biochemistry
(1 time)
|
---
|
1988 Refined structure of chicken skeletal muscle troponin C in the two-calcium state at 2-A resolution.
|
| 56 |
thermodynamic properties of metal free
(1 time)
|
Biochemistry
(1 time)
|
ALS (1 time)
DSC (1 time)
GdmCl (1 time)
|
2006 Equilibrium thermodynamic analysis of amyotrophic lateral sclerosis-associated mutant apo Cu,Zn superoxide dismutases.
|
| 57 |
tri-acylglycerol, phospholipids, apolipoprotein
(1 time)
|
Occupational Medicine
(1 time)
|
HDL (1 time)
|
1990 Effects of age and physical performance capacity on distribution and composition of high-density lipoprotein subfractions in men.
|
| 58 |
triglyceride-apolipoprotein
(1 time)
|
Cardiology
(1 time)
|
LDL (1 time)
VLDL1 (1 time)
|
1998 In vivo studies of VLDL metabolism and LDL heterogeneity.
|
A Search Service for Abbreviation / Long Form